» Articles » PMID: 3497196

Recombinant Interleukin 4 Promotes the Growth of Human T Cells

Overview
Journal J Immunol
Date 1987 Aug 15
PMID 3497196
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, we reported the isolation of a cDNA clone that encodes a polypeptide which has B cell and T cell growth factor activities. The amino acid sequence of this polypeptide deduced from the nucleotide sequence of the cDNA clone showed significant homology with mouse B cell stimulating factor-1. Because of its multiple biologic activities, it was designated interleukin 4 (IL-4). Here we describe the effects of supernatants of Cos-7 mouse cells transfected with the IL-4 coding cDNA clone in a mammalian expression vector, on human thymocyte T cells and T cell clones. The T cell growth-promoting effect of IL-4 on preactivated T cells was not inhibited by monoclonal antibodies against IL-2 or the IL-2 receptor, indicating that the IL-4 activity is independent from IL-2 or the IL-2 receptor. IL-4 induces a low proliferative response in thymocytes and peripheral blood lymphocytes, but the response was considerably enhanced by preactivation of the thymocytes or peripheral blood T cells. Both T4+ and T8+ antigen-specific proliferative and cytotoxic T cell clones and T3 natural killer clones proliferated in response to IL-4. But one of six T4+ and one of four T8+ T cell clones were consistently found to be unresponsive. The proliferative responses to IL-4 were always lower than those obtained with IL-2. Most of the T cell clones generally became unresponsive to IL-4 10 days after stimulation, but still responded well to IL-2. These results indicate that the responsiveness to IL-4 is relatively short lasting and is regulated by activation signals. Interestingly, IL-4 acted in synergy with IL-2 in promoting the growth of T cell clones. Our results establish that IL-4 can act as a T cell growth factor independently of IL-2.

Citing Articles

Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission.

Bai Z, Feng B, McClory S, de Oliveira B, Diorio C, Gregoire C Nature. 2024; 634(8034):702-711.

PMID: 39322664 PMC: 11485231. DOI: 10.1038/s41586-024-07762-w.


Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma.

Shi L, Zhang Y, Feng L, Wang L, Rong W, Wu F Oncotarget. 2017; 8(21):34844-34857.

PMID: 28422742 PMC: 5471016. DOI: 10.18632/oncotarget.16758.


IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity.

Pletneva M, Fan H, Park J, Radojcic V, Jie C, Yu Y Cancer Res. 2009; 69(16):6607-14.

PMID: 19679552 PMC: 2761009. DOI: 10.1158/0008-5472.CAN-09-0508.


General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines.

Kueng H, Leb V, Haiderer D, Raposo G, Thery C, Derdak S J Virol. 2007; 81(16):8666-76.

PMID: 17537846 PMC: 1951353. DOI: 10.1128/JVI.00682-07.


IL-4 increases type 2, but not type 1, cytokine production in CD8+ T cells from mild atopic asthmatics.

Stanciu L, Roberts K, Papadopoulos N, Cho S, Holgate S, Coyle A Respir Res. 2005; 6:67.

PMID: 16001979 PMC: 1198257. DOI: 10.1186/1465-9921-6-67.